## TER: Teradyne, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 0.4% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (39% of avg), momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($183.96)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Teradyne Stock (NASDAQ: TER) News: Shares Hover Near $199 as U.S. Markets Close for the Weekend, Analysts Spotlight AI Test Demand**
- Source: ts2.tech | 20251227T220054 | Somewhat-Bullish | Relevance: 100%
- Teradyne, Inc. (NASDAQ: TER) stock is consolidating below the $200 level as U.S. markets close for the weekend, influenced by accelerating demand related to artificial intelligence infrastructure and ongoing analyst commentary. Shares last traded around $198.90, with a slight gain in extended trading. Analysts, notably Goldman Sachs and Stifel, have recently upgraded Teradyne, citing strong AI test demand and potential growth into 2026.

**2. Teradyne, Inc. $TER Position Decreased by Kempner Capital Management Inc.**
- Source: MarketBeat | 20251227T132442 | Somewhat-Bullish | Relevance: 100%
- Kempner Capital Management Inc. significantly reduced its stake in Teradyne, Inc. by 46.2% in the third quarter, selling 21,192 shares and ending with 24,710 shares valued at $3.40 million. Despite this, Teradyne recently reported strong Q3 earnings, beating analyst estimates with EPS of $0.85 and revenue of $769.2 million, and its stock is trading near a one-year high. Institutional ownership remains very high at 99.77%, and analysts generally rate the stock as a "Moderate Buy" with an average target price of $185.75.

**3. SWS Partners Buys Shares of 15,866 Teradyne, Inc. $TER**
- Source: MarketBeat | 20251227T115818 | Bullish | Relevance: 100%
- SWS Partners initiated a new position in Teradyne, Inc. (NASDAQ:TER) by purchasing 15,866 shares worth approximately $2.18 million in the third quarter, increasing institutional ownership to 99.77%. Despite insider selling by CEO Gregory Smith, analysts maintain a largely positive outlook with a "Moderate Buy" consensus rating and an average price target of $185.75, with some firms like Goldman Sachs upgrading their target to $230. The company reported strong financial results for the last quarter, beating revenue and EPS estimates, and announced a quarterly dividend.

**4. World Investment Advisors Invests $1.01 Million in Teradyne, Inc. $TER**
- Source: MarketBeat | 20251229T131352 | Bullish | Relevance: 98%
- World Investment Advisors recently acquired a new stake of 7,362 shares in Teradyne, Inc. (NASDAQ:TER) valued at approximately $1.01 million. This comes as institutional investors now collectively own 99.77% of the company, and analysts have become more bullish, with Goldman Sachs upgrading TER to a "buy" rating. Despite a CEO insider sale, the company recently beat earnings and revenue estimates and declared a quarterly dividend.

**5. Have $2,000? 3 Top Robotics Stocks to Buy and Hold for at Least a Decade**
- Source: The Globe and Mail | 20251227T102222 | Bullish | Relevance: 80%
- The article recommends three top robotics stocks – Intuitive Surgical, Medtronic, and Teradyne – for investors looking to capitalize on the high-growth robotics industry. Intuitive Surgical is highlighted for its leadership in surgical robotics with its da Vinci system, Medtronic for its Hugo system making inroads in robot-assisted surgery, and Teradyne for its strong semiconductor test business and growing robotics segment. These companies offer significant growth potential due to factors like AI integration, labor shortages, and expanding applications of robotics in healthcare, logistics, and manufacturing.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Goldman Sachs | $230 | $148 | +55% |
| 2025-12-02 | Stifel | $225 | $162 | +39% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Goldman Sachs | up | Buy |
| 2025-12-02 | Stifel | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.08M) |
| Sells | 6 ($0.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+2.1%)
- Blackrock Inc.: 8.4% (-7.2%)
- JPMORGAN CHASE & CO: 5.4% (+126.5%)
- State Street Corpora: 4.0% (+0.3%)
- Ameriprise Financial: 3.0% (+6.8%)

### Key Risks

1. High beta (1.85) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_20 falling (-2.3% 5d) with bearish MACD, trend may be turning.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 38.4x attractive for 46% earnings growth. Quality metrics strong (margin 16%). Balance sheet: low leverage (D/E 0.46). Revenue growth strong at 23% YoY. Analyst sentiment positive (2 raises, avg +47%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $31.4B |
| Beta | 1.85 |
| 52W Range | $65.77 - $205.00 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 38.4 |
| Current P/E | 56.1 |
| YoY Growth | 45.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 2.7% to 0.4% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >4.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.93), momentum weakening. RSI neutral at 59. Volume at 39% of 20MA suggests lack of conviction. OFD pattern: +SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.40% (CS: 55) | Neutral |
| RSI_14 | 58.9 | Neutral |
| MACD Histogram | -0.93 | Bearish |
| vs SMA20 | 1.008x | Above |
| vs SMA50 | 1.110x | Above |
| vs SMA200 | 1.674x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $197.36
- **Stop Loss:** $183.96 (6.8% risk)
- **Target:** $210.76 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 85
- **Position Value:** $16,775.60
- **Portfolio %:** 16.78%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with selective risk appetite and defensive rotation. VIX at 14.2 (2nd percentile) signals low volatility, while positive yield curve (+58bps) and stable economic indicators support continued expansion. Market breadth at 58.7% shows decent participation, but rotation into defensive names and Fed liquidity concerns warrant measured positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $1.36)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.79 | $0.85 | +7.4% |
| 2025Q2 | $0.54 | $0.57 | +4.9% |
| 2025Q1 | $0.62 | $0.75 | +21.7% |
| 2024Q4 | $0.91 | $0.95 | +4.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*